Oneness Biotech Co., Ltd.
4743.TWO
Get informed when a big investor buys or sells
+ FollowMarket Cap$23.06B
Close$
Share Statistics
| Market cap | $23.06 Billion |
|---|---|
| Enterprise Value | $23.05 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.18 |
| Beta | 0.75 |
| Outstanding Shares | 474,672,000 |
Return
| Return on Equity | 0.58% |
|---|---|
| Return on Assets | 0.53% |
| Return on Invested Capital | -5.41% |
Valuation & Multiples
| P/E Ratio | 370.28 |
|---|---|
| PEG | -286.07 |
| Price to Sales | - |
| Price to Book Ratio | 2.29 |
| Enterprise Value to Revenue | 154.46 |
| Enterprise Value to EBIT | -38.37 |
| Enterprise Value to Net Income | 386 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$35.35 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$36.48 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Oneness Biotech Co., Ltd.
180 employees
CEO: Shuling Cheng Oneness Biotech Co., Ltd., headquartered in Taipei City, Taiwan, functions as a biopharmaceutical enterprise primarily dedicated to the discovery and advancement of novel therapeutic agents, in addition to selling pharmaceutical and heal...